Shillong Herald

Lewy Body Dementia Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

 Breaking News
  • No posts were found

Lewy Body Dementia Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

February 20
20:40 2021
Lewy Body Dementia Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

Lewy Body Dementia Market

(Albany, US) DelveInsight has launched a new report on “Lewy Body Dementia Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’sLewy Body Dementia Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Lewy Body Dementia, historical and forecasted epidemiology as well as the Lewy Body Dementia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some of Lewy body dementia facts:

  • LBD is the third-most common cause of dementia, thereby accounting for 5% to 10% of total cases. Lewy body is also estimated to be found in other brain disorders such as Alzheimer’s disease and Parkinson’s disease.
  • Men had a higher incidence of DLB than women
  • Lewy body dementia is a progressive disease which accounted for the 10% to 15% of the total cases of dementia.
  • In the U.K., as per research, among 100 dementia patients, 10 to 15 patients suffer from LBD and hence, this statistic is estimated to boost the Lewy body dementia treatment market.

 

Request for free sample report: https://www.delveinsight.com/sample-request/lewy-body-dementia-market

 

Scope of the Report

  • The report covers the descriptive overview of Lewy Body Dementia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Lewy Body Dementia epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Lewy Body Dementia are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Lewy Body Dementia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Lewy Body Dementia market

 

Lewy body dementia, also known as dementia with Lewy bodies, is the second most common type of progressive dementia after Alzheimer’s disease dementia. Protein deposits, called Lewy bodies, develop in nerve cells in the brain regions involved in thinking, memory and movement (motor control).

Lewy body dementia causes a progressive decline in mental abilities. People with Lewy body dementia may experience visual hallucinations and changes in alertness and attention. Other effects include Parkinson’s disease-like signs and symptoms such as rigid muscles, slow movement and tremors.

 

Request for free sample report: https://www.delveinsight.com/sample-request/lewy-body-dementia-market

 

Some of Lewy Body Dementia Companies:

  • Allergan Plc.
  • Janssen Pharmaceuticals, Inc.
  • Mallinckrodt Pharmaceuticals
  • GlaxoSmithKline
  • Noven Pharmaceuticals, Inc.
  • BioArctic AB
  • Teva Pharmaceuticals
  • Sanofi AG
  • Jazz Pharmaceuticals, Inc.
  • Bayer AG
  • Takeda Pharmaceutical Company Ltd.
  • Mylan NV
  • And Many Others

 

Lewy Body Dementia Drugs Covered:

  • LY3154207
  • ABBV-0805
  • And Many Others

 

Request for Sample Page to view complete list of Drugs Covered: https://www.delveinsight.com/sample-request/lewy-body-dementia-market

 

Table of Contents:

1. Key Insights

2. Executive Summary of Lewy Body Dementia

3. Competitive Intelligence Analysis for Lewy Body Dementia

4. Lewy Body Dementia: Market Overview at a Glance

5. Lewy Body Dementia: Disease Background and Overview

6. Patient Journey

7. Lewy Body Dementia Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Lewy Body Dementia Treatment

11. Marketed Products

12. Emerging Therapies

13. Lewy Body Dementia: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Lewy Body Dementia

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Know how DelveInsight’s advanced competitive intelligence solutions help companies to stay updated on the latest market trends and challenges. Request a free proposal : https://www.delveinsight.com/consulting/competitive-intelligence-services

 

About DelveInsight

DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical, Bio-Tech and Medical devices companies formulate prudent business decisions for improving their performances to stay ahead of the competitors.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/lewy-body-dementia-market